Paper Details

  1. Home
  2. Paper Details

[Prophylactic and therapeutic effects of beclomethasone inhalation on bronchial hyperresponsiveness and asthma: a randomized, double-blind, parallel-group controlled trial].

Author: WuZ, ZhengJ, ZhongN

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Beclomethasone dipropionate (BDP) inhalation significantly improved bronchial hyperresponsiveness (BHR) and symptoms in asthmatic students. BDP also prevented the development of asthma in students with asymptomatic BHR.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To better understand the effects of corticosteroid inhalation on asthma and asymptomatic bronchial hyperresponsiveness (BHR). METHODS: A double blind, randomized study was conducted to compare the effects of beclomethasone dry powder (BDP, 600 micrograms/day) inhalation with placebo on B...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/11263303

データ提供：米国国立医学図書館（NLM）

Inhaling Relief: Beclomethasone and Bronchial Hyperresponsiveness

This study delves into the complex world of asthma and bronchial hyperresponsiveness (BHR), where navigating the desert of respiratory distress can be a constant struggle. The study investigates the potential of beclomethasone inhalation to provide relief and prevent the development of asthma.

A Protective Oasis in the Respiratory Desert

The researchers found that beclomethasone inhalation significantly improved bronchial hyperresponsiveness and reduced the severity of asthmatic symptoms in adolescents. The study suggests that beclomethasone can act as a protective barrier against the development of asthma in individuals with asymptomatic BHR, much like a camel finding shelter from a desert storm.

Breathing Easier in the Desert

This research provides valuable insights into the treatment and prevention of asthma. It offers a glimmer of hope for individuals struggling with respiratory distress, suggesting that beclomethasone inhalation can help them breathe easier and live more fulfilling lives.

Dr.Camel's Conclusion

This research reveals that even in the vast and unforgiving desert of respiratory illness, there are oases of relief and protection. Beclomethasone inhalation offers a potential solution for individuals struggling with asthma and BHR, helping them navigate the challenges of their condition with greater ease.

Date :
  1. Date Completed 2001-05-03
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

11263303

DOI: Digital Object Identifier

11263303

SNS
PICO Info
in preparation
Languages

Chinese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.